Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from ZeroStack ( (ZSTK) ) is now available.
ZeroStack Corp., the first AI-focused asset management firm on Nasdaq, also runs a global pharmaceutical distribution platform via its German subsidiary, Phatebo GmbH, which is its largest revenue contributor. The company is exploring AI-enabled tools within Phatebo to boost efficiency, reduce operational risk, and better match supply with European healthcare demand.
ZeroStack has secured a $6.5 million order from a major pharmaceutical company to support drug distribution in Germany, to be executed through Phatebo. The deal strengthens ZeroStack’s role in the European pharmaceutical supply chain and supports its strategy of using Phatebo’s stable cash flows to scale distribution operations while diversifying investments across the AI sector.
The most recent analyst rating on (ZSTK) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on ZeroStack stock, see the ZSTK Stock Forecast page.
Spark’s Take on ZSTK Stock
According to Spark, TipRanks’ AI Analyst, ZSTK is a Neutral.
The score is primarily held down by weak financial performance: sharp revenue decline, ongoing losses, persistent negative free cash flow, and a significant 2025 increase in debt. Technicals are mixed with neutral momentum but a weak longer-term trend, while valuation offers limited support given the negative P/E and no dividend yield.
To see Spark’s full report on ZSTK stock, click here.
More about ZeroStack
ZeroStack Corp. is a Nasdaq-listed asset management company focused on providing exposure to decentralized artificial intelligence, while also operating a global pharmaceutical distribution business through its wholly owned German subsidiary, Phatebo GmbH. Phatebo, a key revenue contributor for ZeroStack, leverages an established logistics network and regulatory expertise to serve healthcare markets across Europe.
Average Trading Volume: 108,572
Technical Sentiment Signal: Sell
Current Market Cap: $15.85M
For a thorough assessment of ZSTK stock, go to TipRanks’ Stock Analysis page.